TDP-43 pathology in polyglutamine diseases: With reference to amyotrphic lateral sclerosis

Neuropathology

Volumn 34, Issue 1, 2014, Pages 77-82

  Toyoshima, Yasuko ^a   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Polyglutamine disease; RNA binding protein; Stress granules; TDP 43

Indexed keywords

ATAXIN 3; FUSED IN SARCOMA PROTEIN; POLYGLUTAMINE; PROTEIN; SCA2 PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DISEASE ASSOCIATION; HUMAN; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; TDP 43 PROTEINOPATHY;

AMYOTROPHIC LATERAL SCLEROSIS; POLYGLUTAMINE DISEASE; RNA-BINDING PROTEIN; STRESS GRANULES; TDP-43;

AMYOTROPHIC LATERAL SCLEROSIS; DNA-BINDING PROTEINS; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; MACHADO-JOSEPH DISEASE; PEPTIDES; RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIAS;

EID: 84892809454     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12053     Document Type: Article

References (32)

1. Arai T, Hasegawa M, Akiyama H etal. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
2. Neumann M, Sampathu DM, Kwong LK etal. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
3. Amador-Ortiz C, Lin W-L, Ahmed Z etal. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61: 435-445.
4. Arai T, Mackenzie IR, Hasegawa M etal. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 2009; 117: 125-136.
5. Davidson YS, Raby S, Foulds PG etal. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011; 122: 703-713.
6. Hu WT, Josephs KA, Knopman DS etal. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 2008; 116: 215-220.
7. Josephs KA, Whitwell JL, Knopman DS etal. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 2008; 70: 1850-1857.
8. Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology 2009; 29: 566-573.
9. Wilson AC, Dugger BN, Dickson DW, Wang DS. TDP-43 in aging and Alzheimer's disease - a review. Int J Clin Exp Pathol 2011; 4: 147-155.
10. Uryu K, Nakashima-Yasuda H, Forman MS etal. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67: 555-564.
11. Yokota O, Davidson Y, Bigio EH etal. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 2010; 120: 55-66.
12. Higashi S, Iseki E, Yamamoto R etal. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007; 1184: 284-294.
13. Nakashima-Yasuda H, Uryu K, Robinson J etal. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007; 114: 221-229.
14. Yokota O, Davidson Y, Arai T etal. Effect of topographical distribution of alpha-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol 2010; 120: 789-801.
15. Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 2008; 67: 1159-1165.
16. Elden AC, Kim HJ, Hart MP etal. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010; 466: 1069-1075.
17. Tan CF, Yamada M, Toyoshima Y etal. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol 2009; 118: 553-560.
18. Toyoshima Y, Tanaka H, Shimohata M etal. Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol 2011; 122: 375-378.
19. Tada M, Coon EA, Osmand AP etal. Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol 2012; 124: 749-760.
20. Nishihira Y, Tan CF, Onodera O etal. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 2008; 116: 169-182.
21. Yokoseki A, Shiga A, Tan CF etal. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008; 63: 538-542.
22. Sreedharan J, Blair IP, Tripathi VB etal. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668-1672.
23. Yamada M, Tsuji S, Takahashi H. Pathology of CAG repeat diseases. Neuropathology 2000; 20: 319-325.
24. Yamada M, Piao YS, Toyoshima Y, Tsuji S, Takahashi H. Ubiquitinated filamentous inclusions in cerebellar dentate nucleus neurons in dentatorubral-pallidoluysian atrophy contain expanded polyglutamine stretches. Acta Neuropathol 2000; 99: 615-618.
25. Nanetti L, Fancellu R, Tomasello C etal. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 2009; 256: 1926-1928.
26. Hart MP, Brettschneider J, Lee VM, Trojanowski JQ, Gitler AD. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathol 2012; 124: 221-230.
27. Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res 2010; 66: 131-133.
28. Gao FB, Taylor JP. RNA-binding proteins in neurological disease. Brain Res 2012; 1462: 1-2.
29. Ito D, Suzuki N. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurology 2011; 77: 1636-1643.
30. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012; 1462: 61-80.
31. Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G. TDP-43 aggregation in neurodegeneration: are stress granules the key? Brain Res 2012; 1462: 16-25.
32. Nihei Y, Ito D, Suzuki N. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS). J Biol Chem 2012; 287: 41310-41323.